Whether high SgII levels in patients with stable HF are primarily reflective of I/R injury and cardiomyocyte apoptosis is not clear, but given the multifaceted properties of secretoneurin and SgII [3], additional pathophysiology may be associated with SgII as a biomarker and this should be explored in future studies. This evidence concerns the gene SCG2 and hydrops fetalis.